
Leadership Appointments at RQM+
Natalia Elliot | August 28, 2024 | Appointment | Research and Development |ย ย AI and ML, Corporate, RQM+, appointmentย
Ronnie Mahofski and Kevin Rowland both become Executive Vice President and General Manager
Onย August 27, MedTech service provider RQM+ announced their newest leadership appointments. Both Ronnie Mahofski and Kevin Rowland are promoted to executive vice president and general manager.
Ronnie Mahofski joined the RQM+ team in 2015 where he excelled in key roles within Business Development and served as head of mergers and acquisitions. Ronnie will now oversee quality and regulatory consulting as he leads the companyโs business units Consulting Services โ corresponding with the relevant business teams โ and Fern.ai.
Kevin Rowland will lead Jordi Labs as its new general manager โ providing exceptional service to Jordi Labs’ customers and ensuring the safety of products for patients in need โ after serving as an integral part of Jordi Labs for nearly 15 years. In that time, he has been team leader for the GCMS and LCMS groups, as well as Laboratory Manager and Director of R&D. His expertise includes the interpretation of high-resolution accurate mass MS data for identifying non-target, unknown compounds.
โThese strategic appointments reflect RQM+’s dedication to returning to the fundamentals that have made us pioneers in the industry. We are confident that Ronnie and Kevin’s leadership will further our mission of bringing innovative, safe and effective medical technology to the patients who need it,โ John Potthoff, chief executive officer.
Natalia Elliot
Related Content

David Wheadon appointed to board of directors at Seaport Therapeutics
This week, Seaport Therapeutics have appointed David Wheadon MD to their board of directors.

Myeloma UK reveals new Director of Research appointment
UK non-profit organisation Myeloma UK has selected Sarah McDonald as its new Director of Research, …

Abbott CEO to step down after 21 years
After more than two decades at the head of the company, it has emerged that …






